Review regulatory requirements and the use of viral-challenge studies in drug development.
Biopharma companies should not overlook India's growing market.
The biopharmaceutical industry is developing a new approach to controlling variability in raw materials.
USP evaluates raw materials used in the chemical synthesis of peptides.
A review of the past year's trends in biopharmaceutical approvals shows an above average approval rate.
How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?
The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.
The approval and acceptance of monoclonal antibody biosimilars is necessary if the biosimilars market is to experience real growth.
A novel approach to sterile drug product manufacturing that uses a single-use assembly in a multi-product final filling suite with isolator technology offers benefits of efficiency and flexibility.